Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
New mouse models for metabolic bone diseases generated by genome-wide ENU mutagenesis.
Sabrautzki S, Rubio-Aliaga I, Hans W, Fuchs H, Rathkolb B, Calzada-Wack J, Cohrs CM, Klaften M, Seedorf H, Eck S, Benet-Pagès A, Favor J, Esposito I, Strom TM, Wolf E, Lorenz-Depiereux B, Hrabě de Angelis M. Sabrautzki S, et al. Mamm Genome. 2012 Aug;23(7-8):416-30. doi: 10.1007/s00335-012-9397-z. Epub 2012 Apr 21. Mamm Genome. 2012. PMID: 22527485 Free PMC article.
Features and strategies of ENU mouse mutagenesis.
Soewarto D, Klaften M, Rubio-Aliaga I. Soewarto D, et al. Curr Pharm Biotechnol. 2009 Feb;10(2):198-213. doi: 10.2174/138920109787315079. Curr Pharm Biotechnol. 2009. PMID: 19199953 Review.
Dll1 haploinsufficiency in adult mice leads to a complex phenotype affecting metabolic and immunological processes.
Rubio-Aliaga I, Przemeck GK, Fuchs H, Gailus-Durner V, Adler T, Hans W, Horsch M, Rathkolb B, Rozman J, Schrewe A, Wagner S, Hoelter SM, Becker L, Klopstock T, Wurst W, Wolf E, Klingenspor M, Ivandic BT, Busch DH, Beckers J, Hrabé de Angelis M. Rubio-Aliaga I, et al. PLoS One. 2009 Jun 29;4(6):e6054. doi: 10.1371/journal.pone.0006054. PLoS One. 2009. PMID: 19562077 Free PMC article.
The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk.
Pastor-Arroyo EM, Gehring N, Krudewig C, Costantino S, Bettoni C, Knöpfel T, Sabrautzki S, Lorenz-Depiereux B, Pastor J, Strom TM, Hrabě de Angelis M, Camici GG, Paneni F, Wagner CA, Rubio-Aliaga I. Pastor-Arroyo EM, et al. Kidney Int. 2018 Jul;94(1):49-59. doi: 10.1016/j.kint.2018.02.017. Epub 2018 May 5. Kidney Int. 2018. PMID: 29735309 Free article.
67 results